Logo image of LILM

LILIUM NV (LILM) Stock Fundamental Analysis

NASDAQ:LILM - Nasdaq - NL0015000F41 - Common Stock - Currency: USD

0.052  -0.03 (-36.97%)

After market: 0.0564 +0 (+8.46%)

Fundamental Rating

1

Overall LILM gets a fundamental rating of 1 out of 10. We evaluated LILM against 66 industry peers in the Aerospace & Defense industry. Both the profitability and financial health of LILM have multiple concerns. LILM does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year LILM has reported negative net income.
In the past year LILM has reported a negative cash flow from operations.
LILM had negative earnings in each of the past 5 years.
LILM had a negative operating cash flow in each of the past 5 years.
LILM Yearly Net Income VS EBIT VS OCF VS FCFLILM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 -100M -200M -300M -400M

1.2 Ratios

LILM has a worse Return On Assets (-124.74%) than 93.94% of its industry peers.
LILM's Return On Equity of -1050.03% is on the low side compared to the rest of the industry. LILM is outperformed by 83.33% of its industry peers.
Industry RankSector Rank
ROA -124.74%
ROE -1050.03%
ROIC N/A
ROA(3y)-102.55%
ROA(5y)-98.21%
ROE(3y)-431.46%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LILM Yearly ROA, ROE, ROICLILM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 200 -200 -400 -600 -800 -1K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for LILM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LILM Yearly Profit, Operating, Gross MarginsLILM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 -200K -400K -600K -800K

1

2. Health

2.1 Basic Checks

The number of shares outstanding for LILM has been increased compared to 1 year ago.
Compared to 1 year ago, LILM has an improved debt to assets ratio.
LILM Yearly Shares OutstandingLILM Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M
LILM Yearly Total Debt VS Total AssetsLILM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 100M 200M 300M 400M

2.2 Solvency

Based on the Altman-Z score of -7.40, we must say that LILM is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -7.40, LILM is doing worse than 90.91% of the companies in the same industry.
LILM has a Debt/Equity ratio of 0.22. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.22, LILM is in the better half of the industry, outperforming 74.24% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Altman-Z -7.4
ROIC/WACCN/A
WACCN/A
LILM Yearly LT Debt VS Equity VS FCFLILM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 200M -200M

2.3 Liquidity

A Current Ratio of 0.84 indicates that LILM may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.84, LILM is doing worse than 87.88% of the companies in the same industry.
A Quick Ratio of 0.84 indicates that LILM may have some problems paying its short term obligations.
LILM's Quick ratio of 0.84 is on the low side compared to the rest of the industry. LILM is outperformed by 68.18% of its industry peers.
Industry RankSector Rank
Current Ratio 0.84
Quick Ratio 0.84
LILM Yearly Current Assets VS Current LiabilitesLILM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 100M 200M 300M

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 11.14% over the past year.
EPS 1Y (TTM)11.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%98.26%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

LILM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.80% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y23.65%
EPS Next 2Y13.68%
EPS Next 3Y9.58%
EPS Next 5Y22.8%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
LILM Yearly Revenue VS EstimatesLILM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B
LILM Yearly EPS VS EstimatesLILM Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5 1 1.5

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LILM. In the last year negative earnings were reported.
Also next year LILM is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LILM Price Earnings VS Forward Price EarningsLILM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LILM Per share dataLILM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y13.68%
EPS Next 3Y9.58%

0

5. Dividend

5.1 Amount

No dividends for LILM!.
Industry RankSector Rank
Dividend Yield N/A

LILIUM NV

NASDAQ:LILM (11/5/2024, 8:00:02 PM)

After market: 0.0564 +0 (+8.46%)

0.052

-0.03 (-36.97%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)09-25 2024-09-25/bmo
Earnings (Next)12-27 2024-12-27/bmo
Inst Owners2.7%
Inst Owner Change0%
Ins Owners0.06%
Ins Owner Change0%
Market Cap32.90M
Analysts76.36
Price Target1.64 (3053.85%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-16.77%
PT rev (3m)12.17%
EPS NQ rev (1m)11.54%
EPS NQ rev (3m)11.54%
EPS NY rev (1m)15.02%
EPS NY rev (3m)15.02%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.84
P/tB 0.85
EV/EBITDA N/A
EPS(TTM)-0.75
EYN/A
EPS(NY)-0.59
Fwd EYN/A
FCF(TTM)-0.44
FCFYN/A
OCF(TTM)-0.39
OCFYN/A
SpS0
BVpS0.06
TBVpS0.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -124.74%
ROE -1050.03%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-102.55%
ROA(5y)-98.21%
ROE(3y)-431.46%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 226.49%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.84
Quick Ratio 0.84
Altman-Z -7.4
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)208.53%
Cap/Depr(5y)208.96%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)11.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%98.26%
EPS Next Y23.65%
EPS Next 2Y13.68%
EPS Next 3Y9.58%
EPS Next 5Y22.8%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y2.35%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-17.61%
EBIT Next 3Y12.51%
EBIT Next 5Y24.34%
FCF growth 1Y2.26%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y9.96%
OCF growth 3YN/A
OCF growth 5YN/A